Ashvini Keshavan

The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho‐tau Round Robin study

Biomarker discovery in Alzheimer's and neurodegenerative diseases using Nucleic Acid Linked Immuno‐Sandwich Assay

Global multi‐specialty clinician perspectives on the implementation of Alzheimer's disease blood biomarkers

Association of Increase in White Matter Hyperintensity Volume With Rate of Hippocampal Atrophy in a Population-Based Study of Aging

Updating the study protocol: Insight 46 – a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development – phases 2 and 3

Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults

Rates of cortical thinning in Alzheimer’s disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70

The relationship between leisure time physical activity patterns, Alzheimer’s disease markers and cognition

Associations of several common infections with amyloid‐β pathology <i>in vivo</i>: a population‐based study

Neuroimaging, clinical and life course correlates of normal-appearing white matter integrity in 70-year-olds

Methodology dependent sex differences in Aβ‐PET measured with SUVR

Associations between peripheral hearing ability at age 70, brain atrophy and cognitive decline in adults born in the same week of 1946

Population-based blood screening for pre-clinical Alzheimer’s disease: a British birth cohort at age 70

Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study

Adulthood cognitive trajectories over 26 years and brain health at 70 years of age: findings from the 1946 British Birth Cohort

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes

Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory

Investigating the relationship between BMI across adulthood and late life brain pathologies

Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease

A population‐based study of head injury, cognitive function and pathological markers

OUP accepted manuscript

Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype

Increased variability in reaction time is associated with amyloid beta pathology at age 70

Amyloid β influences the relationship between cortical thickness and vascular load

Olfactory testing does not predict β-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort

APOE‐ε4 carriers have superior recall on the ‘What was where?’ visual short‐term memory binding test at age 70, despite a detrimental effect of β‐amyloid

International initiative for harmonization of cerebrospinal fluid diagnostic comments in Alzheimer's disease

Vascular risk factors and amyloid pathology: Additive or interactive associations?